New factory takes AGC Danmark to another level within the corporation
Demand for medication production is now so high that AGC Biologics' Danish unit expects to sell the output of almost full production capacity at the company's new factory within three years after commissioning, expectedly in 2023.
BY ELIZABETH MØNSTED JOHANSEN, TRANSLATED BY DANIEL FRANK CHRISTENSEN
When AGC Biologics' new production facilities enter operation in 2023 and 300 new personnel are hired, the Danish division will be among the largest within the corporation, says Copenhagen Site Head Andrea Porchia.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
AGC Biologics breaks ground on USD 190m Danish factory
For subscribers
